Format

Send to

Choose Destination
Int Immunol. 2013 Oct;25(10):547-51. doi: 10.1093/intimm/dxt039. Epub 2013 Sep 11.

IL-9 and Th9 cells: progress and challenges.

Author information

1
Immunobiology and Transplant Research, Houston Methodist Hospital and Methodist Hospital Research Institute, Texas Medical Center, 6670 Bertner Avenue, Houston, TX 77030, USA.

Abstract

T(h)9 cells are a new subset of helper T cells, and the signature cytokine for T(h)9 cells is IL-9. Both T(h)9 cells and T(h)9 products are implicated in multiple disease settings. Thus, a clear understanding of how T(h)9 cells are induced and controlled is an important and clinically relevant issue. There are different molecular pathways identified thus far in the induction of T(h)9 cells, and activation of such diverse pathways requires integration of signals from TGF-β and IL-4 cytokine receptors as well as costimulatory molecules. These signals converge on the induction of multiple transcription factors that collectively drive the development of T(h)9 cells.

KEYWORDS:

IL-9; Th9; allergy; inflammation

PMID:
24027199
PMCID:
PMC3784066
DOI:
10.1093/intimm/dxt039
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Silverchair Information Systems Icon for PubMed Central
Loading ...
Support Center